Aesculap Implant Systems, LLC
Manufacturers of Surgical Instruments
Aesculap was founded in 1867 in Tuttlingen, Germany and has grown into the largest and one of the most respected manufacturers of surgical instruments in the world. Over the years, Aesculap has continued to evolve into a diversified healthcare corporation by focusing its expertise in the areas of orthopaedics, spinal implants, neurosurgery and vascular systems and sutures.
B. Braun acquired Aesculap in 1996. B. Braun is a private company which was founded in 1839 in Melsungen, Germany. It is one of the world's top ten diversified medical companies with revenues in excess of $4 Billion. Aesculap is the surgical division within the B. Braun family of companies.
Aesculap entered the total joint replacement market in Europe in 1972. Since then, Aesculap has grown to become the 6th largest orthopaedic implant company in the world and it continues to expand its presence. In 1980, Aesculap was one of the first companies to enter the spine market with the introduction of a revolutionary product for anterior cervical fusions, the Caspar retractor and plating system. This retractor system remains the industry's gold standar
In order to be more responsive to its growing customer base in spine and orthopaedics, Aesculap, Inc. formed a new company, Aesculap Implant Systems, Inc. This new company focuses on these unique markets allowing for greater innovation and customer service. Aesculap Implant Systems maintains a surgeon/patient focus with the goal of improved operative procedures and patient outcomes leading to an improved quality of life.
About Aesculap USA
Advances in healthcare are made from a willingness to face change with innovative solutions which shape the future of medicine. This means taking responsibility for recognizing opportunities in the marketplace and identifying the customer’s needs. As a leading healthcare company, Aesculap is fully aware of this responsibility. The brand promise, “Sharing Expertise,” stands for the continual exchange of knowledge and experience in medicine.
Aesculap continues to contribute to medical advancements from the perspective of the healthcare professional; and the patient – through innovation, efficiency and sustainability. As an independent, family-owned business, Aesculap embraces the opportunities presented by the global marketplaceoutcomes leading to an improved quality of life.
The Foundation of our Business
Growth from our own resources – The B. Braun group of companies, including the Aesculap Division, remains a privately-held family business. Company growth is financed through internal resources and innovative strength, and the commitment to uphold this directive for future generations.
Sharing Expertise – Whether it’s with customers, patients, physicians or nurses, sharing expertise is the method by which we all become more efficient and innovative. It is also the way in which we work together to improve the quality of care.
Product Excellence – Aesculap’s history and foundation for business was built upon superior products, and to this, the company remains committed.
Employee Ambassadors – Aesculap has a commitment not only to customers, but also to its employees, who are ambassadors to the marketplace. As the employees prosper and grow, so does the company.
Innovation as a Driving Force – Innovation in products and processes is a driving force, and is a constant spirit that drives Aesculap’s future.